Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ying Peng, Hui Wu, Xueyuan Zhang, Fengyi Zhang, Huanhuan Qi, Yunxi Zhong, Yu Wang, Hua Sang, Guangji Wang & Jianguo Sun. (2015) A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug–drug interaction evaluation. Xenobiotica 45:11, pages 961-977.
Read now
Read now
ChristopherS. Mazur, JohnF. Kenneke, Caroline Tebes-Stevens, MilesS. Okino & JohnC. Lipscomb. (2007) In Vitro Metabolism of the Fungicide and Environmental Contaminant trans-bromuconazole and Implications for Risk Assessment. Journal of Toxicology and Environmental Health, Part A 70:14, pages 1241-1250.
Read now
Read now
James J Cali, Dongping Ma, Mary Sobol, Daniel J Simpson, Susan Frackman, Troy D Good, William J Daily & David Liu. (2006) Luminogenic cytochrome P450 assays. Expert Opinion on Drug Metabolism & Toxicology 2:4, pages 629-645.
Read now
Read now
Articles from other publishers (18)
Ayako Watanabe, Kenji Momo, Katsumi Tanaka, Takeshi Uchikura, Yoshihiro Kiryu, Kanami NiiyamaNorihisa KodairaAiri Matsuzaki & Tadanori Sasaki. (2022) Identification of the Components of Proton Pump Inhibitors and Potassium-Competitive Acid Blocker That Lead to Cardiovascular Events in Working-Age Individuals: A 12-Month Retrospective Cohort Study Using a Large Claims Database. Biological and Pharmaceutical Bulletin 45:9, pages 1373-1377.
Crossref
Crossref
Fausto Meriggi. (2021) Controversial link between proton pump inhibitors and anticancer agents: review of the literature. Tumori Journal 108:3, pages 204-212.
Crossref
Crossref
Nanyong Gao, Xiaodan Zhang, Xiaoqin Hu, Qihui Kong, Jianping Cai, Guoxin Hu & Jianchang Qian. (2022) The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism. Frontiers in Pharmacology 13.
Crossref
Crossref
Prajakta Harish Patil, Puralae Channabasavaiah Jagadish, Fajeelath Fatima, Sumit Birangal, Gurupur Gautham Shenoy, Mahadev Rao, Junaid Farooqui, Himanshu Rastogi, Tarun Sharma & Jakir Pinjari. (2022) Inhibition of Cytochrome P450 Enzyme and Drug-Drug Interaction Potential of Acid
Reducing Agents Used in Management of CDK Inhibitors for Breast Cancer Chemotherapy. Current Drug Metabolism 23:2, pages 137-149.
Crossref
Crossref
Tobias Kanacher, Andreas Lindauer, Enrica Mezzalana, Ingrid Michon, Celine Veau, Jose David Gómez Mantilla, Valerie Nock & Angèle Fleury. (2020) A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine. Pharmaceutics 12:12, pages 1191.
Crossref
Crossref
Hyun‐Ji Kim, Hyunyoung Lee, Hyeon‐Kyeong Ji, Taeho Lee & Kwang‐Hyeon Liu. (2019) Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography–tandem mass spectrometry. Biopharmaceutics & Drug Disposition 40:3-4, pages 101-111.
Crossref
Crossref
Laura Costarelli, Robertina Giacconi, Marco Malavolta, Andrea Basso, Francesco Piacenza, Mauro Provinciali, Marcello G. Maggio, Andrea Corsonello & Fabrizia Lattanzio. (2016) Different transcriptional profiling between senescent and non-senescent human coronary artery endothelial cells (HCAECs) by Omeprazole and Lansoprazole treatment. Biogerontology 18:2, pages 217-236.
Crossref
Crossref
Amalie Møller Sørensen, Cecilie Hurup Hansen, Silvia Bonomo, Lars Olsen, Flemming Steen Jørgensen, Johan Juhl Weisser, Andreas Christopher Kretschmann & Bjarne Styrishave. (2016) Enantioselective endocrine disrupting effects of omeprazole studied in the H295R cell assay and by molecular modeling. Toxicology in Vitro 34, pages 71-80.
Crossref
Crossref
Barbara Ring, Steven A. Wrighton & Michael Mohutsky. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
37
56
.
D. E. Moody, F. Liu & W. B. Fang. (2013) In vitro Inhibition of Methadone and Oxycodone Cytochrome P450-Dependent Metabolism: Reversible Inhibition by H2-Receptor Agonists and Proton-Pump Inhibitors. Journal of Analytical Toxicology 37:8, pages 476-485.
Crossref
Crossref
Eun-Jung Choi, Yin-Jin Jang, Eun-Young Cha, Jae-Gook Shin & Sang Seop Lee. (2013) Identification and Characterization of Novel Alternative Splice Variants of Human Constitutive Androstane Receptor in Liver Samples of Koreans and Caucasians. Drug Metabolism and Disposition 41:4, pages 888-896.
Crossref
Crossref
Tatyana Zvyaga, Shu-Ying Chang, Cliff Chen, Zheng Yang, Ragini Vuppugalla, Jeremy Hurley, Denise Thorndike, Andrew Wagner, Anjaneya Chimalakonda & A. David Rodrigues. (2012) Evaluation of Six Proton Pump Inhibitors As Inhibitors of Various Human Cytochromes P450: Focus on Cytochrome P450 2C19. Drug Metabolism and Disposition 40:9, pages 1698-1711.
Crossref
Crossref
Yan Pan, Kai Hung Tiong, Badrul Amini Abd-Rashid, Zakiah Ismail, Rusli Ismail, Joon Wah Mak & Chin Eng Ong. (2012) Inhibitory effects of cytochrome P450 enzymes CYP2C8, CYP2C9, CYP2C19 and CYP3A4 by Labisia pumila extracts. Journal of Ethnopharmacology 143:2, pages 586-591.
Crossref
Crossref
Xavier Boulenc, Nassim Djebli, Juan Shi, Laurent Perrin, William Brian, Robert Van Horn & Fabrice Hurbin. (2012) Effects of Omeprazole and Genetic Polymorphism of CYP2C19 on the Clopidogrel Active Metabolite. Drug Metabolism and Disposition 40:1, pages 187-197.
Crossref
Crossref
Wenjie Jessie Lu, Valentina Ferlito, Cong Xu, David Alastair Flockhart & Salvatore Caccamese. (2011) Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoforms. Chirality 23:10, pages 891-896.
Crossref
Crossref
James M. Mullin, Melissa Gabello, Lisa J. Murray, Christopher P. Farrell, Jillan Bellows, Kevin R. Wolov, Keith R. Kearney, David Rudolph & James J. Thornton. (2009) Proton pump inhibitors: actions and reactions. Drug Discovery Today 14:13-14, pages 647-660.
Crossref
Crossref
Kyung-Ah Seo, Hyunmi Kim, Hei-Young Ku, Hee-Jeong Ahn, Soo-Jin Park, Soo Kyung Bae, Jae-Gook Shin & Kwang-Hyeon Liu. (2008) The monoterpenoids citral and geraniol are moderate inhibitors of CYP2B6 hydroxylase activity. Chemico-Biological Interactions 174:3, pages 141-146.
Crossref
Crossref
Hortensia Alonso-Navarro, Félix J. Jiménez-Jiménez & José A. García-Agúndez. (2006) Papel del polimorfismo genético CYP2C19 en los efectos adversos a fármacos y en el riesgo para diversas enfermedades. Medicina Clínica 126:18, pages 697-706.
Crossref
Crossref